HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$1.02
Day range
$0.89 - $0.99
Year range
$0.76 - $13.59
Market cap
35.74M USD
Avg Volume
234.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.53M | 31.33% |
Net income | -4.97M | 41.30% |
Net profit margin | — | — |
Earnings per share | -0.14 | — |
EBITDA | -4.48M | -31.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.67M | 6.24% |
Total assets | 11.43M | 0.24% |
Total liabilities | 9.08M | -40.53% |
Total equity | 2.35M | — |
Shares outstanding | 38.26M | — |
Price to book | 17.00 | — |
Return on assets | -81.29% | — |
Return on capital | -99.56% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.97M | 41.30% |
Cash from operations | -5.28M | -23.39% |
Cash from investing | -43.00K | -437.50% |
Cash from financing | — | — |
Net change in cash | -5.32M | -429.15% |
Free cash flow | -3.78M | -278.47% |
About
Founded
2021
Headquarters
Website
Employees
13
